MFS
REGN icon

Monetta Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Monetta Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Hold
2,060
– – 1.23% 23
2025
Q4 		$1.59M Buy
+2,060
New +$1.4M 1.14% 21
2018
Q4 		– Sell
-4,400
Closed -$1.78M – 46
2018
Q3 		$1.78M Buy
+4,400
New +$1.67M 1.08% 21

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Monetta Financial Services's REGN Position: Q1 2026 in Review

Monetta Financial Services held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 2,060 shares worth $1.59M. The position accounts for 1.23% of the portfolio, ranked #23.

Monetta Financial Services first reported a position in REGN in Q3 2018 and has held it in 3 quarters since. The position peaked at $1.78M in Q3 2018. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Monetta Financial Services held 2,060 shares of Regeneron Pharmaceuticals worth $1.59M as of Q1 2026.
  • Monetta Financial Services left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 1.23% of Monetta Financial Services's portfolio in Q1 2026, its #23 holding.
  • Monetta Financial Services first reported a position in Regeneron Pharmaceuticals in Q3 2018 and has held it in 3 quarters since.
  • Monetta Financial Services's Regeneron Pharmaceuticals position peaked at $1.78M in Q3 2018.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Monetta Financial Services's 13F filing for Q1 2026, filed 13 May 2026.